pillbase.ru

EMPLICITI

Active substance: elotuzumab

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ELOTUZUMAB 300 mg/1

United StatesActive

Marketing holder: E.R. Squibb & Sons, L.L.C.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Эмплисити®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 300 мг, 300 мг (original in Russian, GRLS)
    ЛП-№(000275)-(РГ-RU)
    Бристол-Майерс Сквибб Компани
  • Эмплисити®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 300 мг, (original in Russian, GRLS)
    ЛП-004241
    Бристол-Майерс Сквибб Компани
EU 1
  • Empliciti
    Elotuzumab
    EMEA/H/C/003967
    Bristol-Myers Squibb Pharma EEIG
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3555-7d3c-8579-9ddc7a26f245,01a120c5-1df4-771c-8832-31f1626a3ab3;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4d2b-7b9c-8b40-59e283135acf,01a1208d-0086-7127-88c8-284b320ce148;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0003-2291
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0003-2291 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0003-2291 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0003-2291 · Verified 2026-10-09 · open in source